Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
36.70
+3.47 (10.44%)
At close: Apr 24, 2025, 4:00 PM
36.17
-0.53 (-1.44%)
Pre-market: Apr 25, 2025, 5:01 AM EDT
Summit Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 104.86 | 71.43 | 348.61 | 71.79 | 66.42 | Upgrade
|
| Short-Term Investments | 307.49 | 114.82 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 412.35 | 186.24 | 348.61 | 71.79 | 66.42 | Upgrade
|
| Cash Growth | 121.41% | -46.58% | 385.59% | 8.09% | 4.03% | Upgrade
|
| Accounts Receivable | - | - | 0.35 | 1.46 | 0.33 | Upgrade
|
| Other Receivables | 0.56 | 0.85 | 5.77 | 15.7 | 9.86 | Upgrade
|
| Receivables | 0.56 | 0.85 | 6.12 | 17.16 | 10.19 | Upgrade
|
| Prepaid Expenses | 10.52 | 2.62 | 1.5 | 7.16 | 9.55 | Upgrade
|
| Restricted Cash | 0.33 | - | 300 | - | - | Upgrade
|
| Other Current Assets | - | - | 0.49 | 1.2 | 1.52 | Upgrade
|
| Total Current Assets | 423.75 | 189.71 | 656.71 | 97.31 | 87.67 | Upgrade
|
| Property, Plant & Equipment | 7.4 | 6.06 | 5.08 | 3.48 | 1.28 | Upgrade
|
| Goodwill | 1.86 | 1.89 | 1.8 | 2.01 | 2.03 | Upgrade
|
| Other Intangible Assets | - | - | - | 10.4 | 11.52 | Upgrade
|
| Other Long-Term Assets | 2.55 | 5.28 | 0.58 | 0.17 | - | Upgrade
|
| Total Assets | 435.56 | 202.95 | 664.17 | 113.37 | 102.5 | Upgrade
|
| Accounts Payable | 4.64 | 2.67 | 0.36 | 4.37 | 6.14 | Upgrade
|
| Accrued Expenses | 31.53 | 14.21 | 16.31 | 11.32 | 4.26 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 19.77 | - | - | Upgrade
|
| Current Portion of Leases | 3.77 | 2.81 | 1.69 | 1.09 | 0.39 | Upgrade
|
| Current Unearned Revenue | - | - | - | 7.94 | 8.37 | Upgrade
|
| Other Current Liabilities | 1.8 | 0.72 | 0.66 | 0.9 | 0.73 | Upgrade
|
| Total Current Liabilities | 41.73 | 20.41 | 38.78 | 25.62 | 19.89 | Upgrade
|
| Long-Term Debt | - | 100 | 494.54 | - | - | Upgrade
|
| Long-Term Leases | 3.45 | 3.29 | 2.76 | 1.69 | 0.08 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 0.57 | Upgrade
|
| Other Long-Term Liabilities | 1.63 | 1.56 | 1.43 | 2.78 | 2.51 | Upgrade
|
| Total Liabilities | 46.81 | 125.26 | 537.51 | 30.09 | 23.05 | Upgrade
|
| Common Stock | 7.38 | 7.02 | 2.11 | 0.98 | 0.83 | Upgrade
|
| Additional Paid-In Capital | 1,598 | 1,066 | 504.77 | 384.05 | 293.37 | Upgrade
|
| Retained Earnings | -1,215 | -993.26 | -378.33 | -299.55 | -210.95 | Upgrade
|
| Comprehensive Income & Other | -2.29 | -2.45 | -1.89 | -2.2 | -3.79 | Upgrade
|
| Shareholders' Equity | 388.75 | 77.69 | 126.65 | 83.28 | 79.45 | Upgrade
|
| Total Liabilities & Equity | 435.56 | 202.95 | 664.17 | 113.37 | 102.5 | Upgrade
|
| Total Debt | 7.22 | 106.1 | 518.76 | 2.78 | 0.47 | Upgrade
|
| Net Cash (Debt) | 405.13 | 80.14 | -170.16 | 69.01 | 65.95 | Upgrade
|
| Net Cash Growth | 405.51% | - | - | 4.63% | 4.77% | Upgrade
|
| Net Cash Per Share | 0.56 | 0.13 | -0.88 | 0.75 | 0.95 | Upgrade
|
| Filing Date Shares Outstanding | 737.68 | 701.7 | 697.69 | 98.12 | 82.92 | Upgrade
|
| Total Common Shares Outstanding | 737.63 | 701.66 | 211.09 | 98.04 | 82.58 | Upgrade
|
| Working Capital | 382.02 | 169.31 | 617.93 | 71.69 | 67.78 | Upgrade
|
| Book Value Per Share | 0.53 | 0.11 | 0.60 | 0.85 | 0.96 | Upgrade
|
| Tangible Book Value | 386.88 | 75.8 | 124.86 | 70.88 | 65.91 | Upgrade
|
| Tangible Book Value Per Share | 0.52 | 0.11 | 0.59 | 0.72 | 0.80 | Upgrade
|
| Machinery | 1.05 | 0.92 | 1.39 | 1.37 | 1.56 | Upgrade
|
| Leasehold Improvements | 0.32 | 0.33 | 0.81 | 0.37 | 0.29 | Upgrade
|
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.